In a multivariate regression model IL28B polymorphism was the best predictor for therapy response between other predictors such as ethnic background, baseline viral load, hepatic fibrosis stage, fasting glucose level, BMI and RBV starting dose (RVR stronger than IL28B) [31]. Here, IFNL3 is linked to Hepatic fibrosis.